The US administration has decided to restrict the import of products from the Chinese biotechnology company BGI Group and its affiliated enterprises. The American administration leveled accusations against these companies regarding their alleged involvement in forced labor in the Xinjiang region of China. This action was announced by the US government on Wednesday, and starting Thursday, US Customs and Border Protection (CBP) will begin obstructing the entry of these companies' products into the United States.
The sanctions affect not only BGI Group but also BGI Genomics and MGI Tech. BGI Group is a leading company in genetic sequencing technologies.
According to the US Department of Homeland Security (DHS), these companies either source raw materials from Xinjiang or participate in activities linked to the forced labor of ethnic groups in conjunction with the regional government. Representatives of the Uyghur community are among those mentioned as affected. The Department stated that it possesses credible information, including corporate and governmental reports, concerning these companies. DHS asserts that BGI Group and its affiliates supported activities related to genetic testing in Xinjiang.
The American department believes that the collection and analysis of genetic material may facilitate the monitoring and suppression of ethnic minorities by the Chinese government.
Meanwhile, BGI Group has rejected the accusations made by the US government. In a statement released on Wednesday, the company emphasized that it is not involved in any form of forced labor. The company stated: 'We strongly oppose all forms of forced labor.' BGI Group also clarified that it is privately owned, does not provide services to patients in the US, and does not have access to the genetic data of American citizens.
This move comes amid biotechnology becoming an important area in the economic and technological competition between the US and China. Last week, the US Treasury proposed new restrictions aimed at limiting American investments in fields such as biotechnology, artificial intelligence, and supercomputers in countries like China. US politicians and senators have expressed concerns about BGI Group for many years. They believed that the company's ties to the Chinese government and its access to extensive genetic data could harm US national security and business interests.
The US Department of Defense had previously classified BGI Group, BGI Genomics, and MGI Tech as Chinese military companies.
This US decision was made shortly before the anticipated meeting between Chinese President Xi Jinping and US President Donald Trump next month. The leaders' meeting is expected to take place in Shenzhen, a southern city in China where BGI Group is headquartered. Following this, Xi Jinping may visit Florida in December for a G20 leaders' summit, where a fourth meeting with Trump might occur this year. Both countries are attempting to stabilize bilateral relations amidst trade tensions.
The new restrictions are introduced under the Uyghur Forced Labor Prevention Act. This act was signed by then-US President Joe Biden in late 2021. In August, the Trump administration added another 43 Chinese companies to the blacklist under this law, bringing the total number of prohibited organizations to 187. Nevertheless, the Chinese government consistently denies allegations of human rights abuses and forced labor in Xinjiang. Beijing maintains that policies in Xinjiang are aimed at combating terrorism and maintaining stability in the region. US Secretary of Homeland Security Marco Wen Mullin stated his determination to protect the interests of American workers from the alleged activities of foreign companies related to forced labor.